Evofem Biosciences (EVFM) Depreciation and Depletion (2023 - 2026)
Evofem Biosciences' Depreciation and Depletion was $4,000 in Q2 2026, unchanged from $4,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Depreciation and Depletion (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Evofem Biosciences' Depreciation and Depletion was $17,000 through Jun 30, 2026, down 19.0% year-over-year; for FY2025, it came in at $19,000, down 36.7% from FY2024.
- In earlier years, Depreciation and Depletion was $30,000 in FY2024 (-94.0%) and $500,000 in FY2023.
- Quarterly Depreciation and Depletion has moved between $4,000 (Q2 2025) and $500,000 (Q3 2023) over five years.
- Across the past five years, year-over-year decline in Depreciation and Depletion ran from 0.0% in Q2 2026 to 98.8% in Q3 2024.
- Per Business Quant data, EVFM's Depreciation and Depletion in the three quarters before Q2 2026 was $4,000 (Q1 2026), $5,000 (Q4 2025) and $4,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,132.26 Bn | 1,100.85 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 634.57 Bn | 554.43 Bn | 17.30 Bn | - |
| 3 | AbbVie | 505.88 Bn | 478.99 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 291.59 Bn | 255.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.00 Bn | 238.69 Bn | 12.86 Bn | - |
| 7 | Amgen | 238.10 Bn | 193.50 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 195.13 Bn | 169.32 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 171.11 Bn | 117.76 Bn | 10.94 Bn | - |
| 10 | Evofem Biosciences | 878,961.72 | 878,961.72 | 2.12 Mn | 4,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,000.00 |
| Mar 31, 2026 | 4,000.00 |
| Dec 31, 2025 | 5,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 4,000.00 |
| Mar 31, 2025 | 6,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 245,000.00 |
API Access
Evofem Biosciences Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();